Aberrant Cell Cycle Regulation in Cervical Carcinoma

참고문헌 (97)

1. "Ferlay J. Global cancer statistics.", pp.33~64 (1999)
2. "evasion from host-cell control in early events in carcinogenesis.", pp.690~8 (2000)
3. "Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix.", pp.238~46 (2001)
4. "Riethdorf S. Role of cell-cycle regulatory proteins in gynecological cancer.", pp.224~44 (2003)
5. "Cancer cell cycle control.", pp.4772~80 (1999)
6. "positive and negative regulators of G1-phase progression.", pp.1501~12 (1999)
7. "Jakowicki JA. Alterations of pRb1-cyclin D1-cdk4", 6-p16INK4A pathway in endometrial carcinogenesis., 2004, 1~12
8. "et al. p16INK4A positivity in benign", pp.610~5 (2004)
9. "Kim JH. Alterations of CDKN2 gene in paraffin-embedded tumor tissues of human stomach", pp.109~14 (1998)
10. "Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 2001" (1982)
11. "Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.", pp.12754~9 (1999)
12. "Yamamoto K. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm.", pp.476~85 (2003)
13. "gene is not altered in uterine cervical carcinomas or cell lines.", pp.16 26~31 (1996), CDKN2[DOI]
14. "Dipaolo JA. CDKN2 in HPV-positive and HPV- negative cervical-carcinoma cell lines.", pp.226~30 (1995)
15. "Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.", pp.375~83 (2002)
16. "et al. Overexpression of p16 as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.", pp.276~84 (2001)
17. "Marjoniemi VM. Immunohistochemistry in gynaecological pathology", pp.109~19 (2004)
18. "et al. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.", areva g, pp.58~ (2004)
19. "Tommasino M. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest.", pp.4705~12 (2001)
20. "Von Knebel Doeberitz M. New molecular tools for efficient screening of cervical cancer.", pp.123~8 (2001)
21. "et al. p16INK4A as a marker for cervical dyskaryosis CIN and cGIN in cervical biopsies and ThinPrep smears.", pp.56~63 (2003)
22. "Hughson MD. The predictive value of p16 and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.", pp.894~901 (2004)
23. "Gupta P. Overexpression of p16INK4A in liquid-based specimens as marker of cervical dysplasia and neoplasia.", pp.365~70 (2002)
24. "Hughson MD. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents.", pp.267~73 (2005)
25. "Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions.", pp.5439~47 (2004)
26. "et al. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300", CBP-associated factor, 2001, 797~811
27. "et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.", pp.6159~73 (2003)
28. "Kim JW. Correlation between G1 cyclins and HPV in the uterine cervix.", pp.339~47 (1997)
29. "et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.", pp.341~7 (2001)
30. "Herrington CS. Differential cell cycle regulation by low- and high-risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix.", pp.2941~5 (1998)
31. "Stoler MH. Cyclin D1 gene expression in human cervical neoplasia.", pp.418~25 (1996)
32. "Talpaz M. Abnormalities in the PRAD1 oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.", pp.584~1 90 (1995)
33. "Holm R. Aberrant expression of the cell cycle associated proteins TP53 and EGFR in cervical carcinomas.", pp.223~8 (1999)
34. "Wong YF. Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix." (2001)
35. "DiMaio D. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells.", pp.3079~86 (2004)
36. "Roberts JM. Living with or without cyclins and cyclin-dependent kinases.", pp.2699~711 (2004)
37. "Reddy EP. Cell cycle control in mammalian cells role of cyclins", pp.211~9 (1995), growth suppressor genes and cyclin-dependent kinase inhibitors
38. "et al. Alteration of the CDKN2", p16 gene is not required for HPV positive uterine cervical cancer cell lines., 2000, pp.yoshi(uchi m), 534~41
39. "Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads.", pp.226~31 (2004)
40. "a novel inhibitor of G1 cyclin-cdk protein kinase activity is related to p21. Cell 1994", pp.67~74
41. "Peters G. Evidence for different modes of action of cyclin-dependent kinase inhibitors p15 and p16 bind to kinases p21 and p27 bind to cyclins. Oncogene 1995", pp.1581~8
42. "et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994", pp.625~38, Kjerulff AA
43. "et al. Changes in retinoblastoma gene expression during cervical cancer progression.", pp.275~86 (2002)
44. "et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994", pp.2945~9
45. "Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993", pp.499~511
46. "Nakajima T. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998", pp.580~5
47. "and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer", pp.907~12 (1995)
48. "Chong KY. Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinomas. Virology 1993", pp.1042~6
49. "Sataar N. Relation between retinoblastoma and p53 proteins in human papilloma viruses 16", 18 positive and negative cancers of the uterine cervix. J Clin Pathol 1997, 413~6
50. "Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991", pp.5523~7
51. "et al. High level HPV-16 E7 oncoprotein expression correlates with reduced pRb- levels in cervical biopsies. FASEB J 2004", pp.1120~2
52. "et al. WAF1", CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 1169~74
53. "Givol D. Induction of WAF1", CIP1 by a p53-independent pathway. Cancer Res 1994, 3391~5
54. "Holm R. Expression of p53 and p21 proteins in high- grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection. Int J Gynecol Pathol 1999", pp.5~11
55. "Kim JW. Underexpression of cyclin-dependent kinase inhibitors in cervical carcinoma. Gynecol Oncol 1998", pp.38~45
56. "Lee TT. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix overexpression of p53 predicts poor disease outcome. Gynecol Oncol 2001", pp.348~54
57. "Kristensen GB. Corrigendum to ？Expression of p27 and p16 protein in early squamous cervical cancer and its relation to prognosis？. Gynecol Oncol 2004", pp.730~
58. "Herrington CS. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low", pp.1300~7
59. "Goldstein DJ. p53- independent expression of p21WAF1", Cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Mod Pathol 1997, 578~84
60. "Fujii S. Expression of p21WAF1", CIP1 in adenocarcinoma of the uterine cervix a possible immunohistochemical marker of a favorable prognosis. Cancer 1998, 2409~17
61. "Karlsson M. Immunohistochemical expression of p53 correlation with clinical outcome. Int J Gynecol Cancer 2002", pp.290~2 8
62. "et al. Aberrant expression of p21", pp.93~8, in cervical carcinoma. Cancer Lett 2001
63. "Weinstein IB. Multiple functions of p27 and its alterations in tumor cells"
64. "Nikaido T. Expression of the cell cycle regulator p27 and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27", pp.3005~11
65. "Chou YY. Down- regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms. Gynecol Oncol 2002", pp.524~8
66. "Muntz HG. Evaluation of p27 in preinvasive and invasive malignancies of the cervix. Gynecol Oncol 2003", pp.40~4
67. "et al. Expression of cyclin E and p27KIP1 in cervical carcinoma. Cancer Lett 2000", pp.41~50
68. "Palombini L. Cyclin dependent kinase inhibitor p27KIP1 expression in normal and neoplastic cervical epithelium. J Clin Pathol 1999", pp.880~7
69. "et al. Decreased expression of the CDK inhibitor p27KIP1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis. Gynecol Oncol 2004", zan(ni gf), pp.776~83
70. "Torhorst J. Association of p27KIP1 cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer Res 1998", pp.3991~8
71. "Zetterberg A. Abnormal expression pattern of cyclin E in tumour cells. Int J Cancer 2003", pp.369~75
72. "et al. Expression of cyclins E1 and E2 during mouse development and in neoplasia. Proc Natl Acad Sci USA 2001", pp.13138~43
73. "Rutka JT. Current concepts in neuro-oncology", pp.1000~15
74. "Dutta A. In vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998", pp.1238~46
75. "Jansen-Durr P. Inactivation of the CDK inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 1996", pp.2323~30
76. "Herrington CS. Loss of cytokeratin 14 expression is related to human papillomavirus type and lesion grade in squamous intraepithelial lesions of the cervix. Hum Pathol 2001", pp.1351~5
77. "Herrington CS. Evidence for keratinocyte immortalization in high-grade squamous intraepithelial lesions of the cervix infected with high-risk human papillomaviruses. Lab Invest 2000", pp.539~44
78. "and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001", pp.884~67 91
79. "Fujii S. Immunohistochemical detection of sex steroid receptors and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 1998", pp.1709~19
80. "Kroemer G. Cell death by mitotic catastrophe", pp.2825~37
81. "Reed SI. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 1992" (1958)
82. "Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000", pp.~7
83. "Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 1997", pp.2101~11
84. "McCormick F. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 2003", pp.233~45
85. "Meijer L. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci 2002", pp.417~25
86. "et al. Correlation between p14 expression and HPV infection in uterine cervical cancer. Cancer Lett 2004", pp.31~7
87. "Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995", pp.993~1000
88. "et al. The alternative product from the human CDKN2A locus participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998", pp.5001~14
89. "Loning T. Expression of cyclin-dependent kinase inhibitors p16MTS1 and p27KIP1 in HPV- positive and HPV-negative cervical adenocarcinomas. Virchows Arch 2001", pp.55~61
90. "et al. E7 proteins from oncogenic human papillomavirus types transactivate p73 role in cervical intraepithelial neoplasia. Br J Cancer 2002", pp.263~8
91. "et al. Monoallelically expressed gene related to p53 at 1p36 a region frequently deleted in neuroblastoma and other human cancers. Cell 1997", pp.809~19
92. "Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992", pp.1237~45
93. "Levine AJ. Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol 1993", pp.4107~14
94. "et al. Altered expression of mdm-2 and its association with p53 protein status tumor-cell-proliferation rate and prognosis in cervical neoplasia. Int J Cancer 1997", pp.421~5
95. "et al. Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines. Mol Carcinog 1995", pp.173~81
96. "Holm R. TP53 alterations in relation to the cell cycle-associated proteins p21 and EGFR in cancers of the uterine corpus. J Pathol 1999", pp.556~62
97. "et al. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas. Cancer 1995", pp.57~66

관련 논문AI추천